GGrantIndex
← Search

COMPASSIONATE USE OF ARSENIC TRIOXIDE IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA

$0M01FY2000RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

Abstract

To induce and maintain a complete remission in patients with Acute Promyelocytic Leukemia using the drug Arsenic Trioxide. The patient's response will be assessed by normalization of the blood counts, bone marrow and PCR negativity for PML/RAR transcripts.

View original record on NIH RePORTER →